Exploring Novel Biologics Treatment in Asthma Care

Many people are treated for severe, uncontrolled Asthma which is associated with a high risk of hospitalization. Some people with different types of Asthma was offered a new type of treatment alongside their usual asthma medicines – Monoclonal Antibodies, known as Biologics.

Professor Michael Wechsler from the National Jewish Health Hospital in Denver, USA, whose research focuses on novel Asthma therapy and biologics treatment for Asthma and related diseases, addresses the current challenges of Asthma care with the use of Biologics. You will find out how treatment with biologics can improve symptoms of asthma and reduce asthma attacks, learn the differences between the biologics treatment and classic asthma treatment, and discover which groups of patients could likely be treated successfully with biologics therapy.